Angiogenesis in chronic liver disease and its complications. - Wikidata - wikimedia - TriplyDB

Angiogenesis in chronic liver disease and its complications.

Angiogenesis in chronic liver disease and its complications.

http://www.wikidata.org/entity/Q37809119

about

Mechanisms of adaptation of the hepatic vasculature to the deteriorating conditions of blood circulation in liver cirrhosis Hypoxia-inducible factors as molecular targets for liver diseases Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background Splanchnic-aortic inflammatory axis in experimental portal hypertension Angiogenesis and liver fibrosis Bevacizumab attenuates hepatic fibrosis in rats by inhibiting activation of hepatic stellate cells Inhibition of vascular endothelial growth factor signaling facilitates liver repair from acute ethanol-induced injury in zebrafish Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease.CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis.Lipid-induced toxicity stimulates hepatocytes to release angiogenic microparticles that require Vanin-1 for uptake by endothelial cells.Interconnections between autophagy and the coagulation cascade in hepatocellular carcinoma.A 3' UTR SNP in COL18A1 is associated with susceptibility to HBV related hepatocellular carcinoma in Chinese: three independent case-control studies Tumor endothelial inflammation predicts clinical outcome in diverse human cancers A new conversation between radiology and pathology-identifying microvascular architecture in stages of cirrhosis via diffraction enhanced imaging in vitro.Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.Hepatic proliferation and angiogenesis markers are increased after portal deprivation in rats: a study of molecular, histological and radiological changes.Long-term efficacy of subtotal splenectomy due to portal hypertension in cirrhotic patients Placental growth factor inhibition modulates the interplay between hypoxia and unfolded protein response in hepatocellular carcinoma.Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.Formylpeptide receptor 1 mediates the tumorigenicity of human hepatocellular carcinoma cells.The Effects of Taoren-Honghua Herb Pair on Pathological Microvessel and Angiogenesis-Associated Signaling Pathway in Mice Model of CCl4-Induced Chronic Liver Disease Kinsenoside screening with a microfluidic chip attenuates gouty arthritis through inactivating NF-κB signaling in macrophages and protecting endothelial cells.Characterization of hepatocellular carcinoma related genes and metabolites in human nonalcoholic fatty liver disease.Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver disease The role of chemokines in acute and chronic hepatitis C infection.Endoplasmic reticulum stress and angiogenesis: is there an interaction between them?Review of angiogenesis in hepatocellular carcinoma.Update on implications and mechanisms of angiogenesis in liver fibrosis.Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment.Targeting the tumor stroma in hepatocellular carcinoma.Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?Difference of polymorphism VEGF-gene rs699947 in Indonesian chronic liver disease population.The role of macrophages in obesity-driven chronic liver disease.Downregulation of HDAC6 promotes angiogenesis in hepatocellular carcinoma cells and predicts poor prognosis in liver transplantation patients.4-methylumbelliferone inhibits hepatocellular carcinoma growth by decreasing IL-6 production and angiogenesis.Endostar, a novel human recombinant endostatin, attenuates liver fibrosis in CCl4-induced mice.Angiogenesis and Fibrogenesis in Chronic Liver Diseases.Embrionary way to create a fatty liver in portal hypertension.Down-modulation of TNFSF15 in ovarian cancer by VEGF and MCP-1 is a pre-requisite for tumor neovascularization.

P2860

Q26744190-B09125A7-CB4E-4F74-8A41-4673A0B39013 Q26752304-0A5EABAC-20B1-4BFF-9543-9D4991D60A33 Q26765175-697038DD-CC15-4357-8677-E24915988283 Q26995820-EA16028E-98DF-4599-8240-9D8CCE162EB6 Q28082569-23D4660C-60C2-487D-95E6-768AE5CC1CF5 Q28536257-8D486ACD-6B3C-49C0-A872-1249BE53649D Q28820975-4D22700F-8968-489D-A5C6-6E172AADAE2A Q30251565-1EFA0D79-D697-448D-9174-9563997A53CC Q30596736-444697D9-3B38-418B-B88E-353C130EBD1D Q33593809-6A587E0F-94AA-4217-B72F-81FA48C87827 Q33720303-727DB7CD-4F60-4BB4-93BA-9F646A6C6701 Q34213827-D146577A-D21B-4FBC-9AF6-2F66CE286E88 Q34441112-ED223FE3-91D2-4619-BBAF-93048B0E17E0 Q35087916-3EF21C3D-0490-4E7D-B275-14433B10B599 Q35136411-0798292A-5232-4856-A9C0-061BD506F63C Q35645088-02310D4F-2345-4AB2-9B2C-8853E46EAE69 Q35709044-F5BEDBC5-190B-41A4-AA99-259DE8CB30F5 Q35890853-691F075E-5FE8-482C-AD45-349944D983E2 Q36561567-F73D1FCF-0083-4AD7-BF5E-3C69F8F3FBD0 Q36625697-6A7D8D8C-6803-43BB-8FBC-771B2EEF65A9 Q36711055-7CBB3320-7E5F-49BC-B28F-4E316D71ED23 Q36933012-363C6A2F-EF6B-402E-BAF8-28A47E8C318F Q37330831-C123C1AE-EF55-4BB9-9AEE-ED2445BBFFB9 Q37622144-FB3C2C07-AFC2-4CDE-B7CA-8621E28817A4 Q37657130-15984F5E-51F3-4DC8-83E2-ECA3E8E52E2C Q38129709-FD2193CD-77F8-47D3-9ED0-F6DD07D60197 Q38176096-00BB685E-D990-45C5-AFE0-42B537799D57 Q38188582-C616D114-20EB-4CA7-A857-68F211336B74 Q38246718-3651C023-7829-4FD3-8001-3BC1DDA85B8C Q38334735-79591367-CD1F-4051-B106-86E7A34BD97F Q38366586-9772243C-4025-444A-BEAF-554D2E6CF274 Q38554626-F99D0006-8675-4E44-B87E-F4DE4EA11A01 Q38610074-2EE994CF-7D4D-415B-8EAF-FE43598F8869 Q38758810-E9EE89A5-8CC2-4939-BA4A-9CB99D999539 Q38862725-7D0F15D3-40FF-4AE6-81BB-0B60FAFBAFD7 Q38886114-514233D9-EA73-4B38-8562-6AC157743438 Q38990632-647875C3-12B1-4143-AB07-28BD5EEC3B2D Q39140170-27517E97-4A7E-433E-BDA0-B9FF2403BCB5 Q39345271-A753B80F-D9F2-4E41-A868-CF7A5DBF4080 Q39419250-7B4177AB-20B8-4FB6-AFA0-006C98CD082E

P2860

Angiogenesis in chronic liver disease and its complications.

http://www.wikidata.org/entity/Q37809119

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Angiogenesis in chronic liver disease and its complications.

@en

Angiogenesis in chronic liver disease and its complications.

@nl

type

label

Angiogenesis in chronic liver disease and its complications.

@en

Angiogenesis in chronic liver disease and its complications.

@nl

prefLabel

Angiogenesis in chronic liver disease and its complications.

@en

Angiogenesis in chronic liver disease and its complications.

@nl

P1433

Q37809119-E4358402-1936-4C27-B2F7-103A4B731C52

P1476

Q37809119-672E7CBF-B2B3-4789-82CA-09EDC883BA5C

P2093

Q37809119-0A0E0C8A-AB53-44B0-ADA5-961165B3128A

Q37809119-22DFBA7C-F82E-4214-8320-FDBB405A19A3

Q37809119-73591189-5FE8-4BFD-9F94-B4819AF61695

Q37809119-73A08CB3-20EF-45CC-994F-B87B8532FDE9

Q37809119-7A223034-7FF4-4821-B28D-C6FC70427F82

Q37809119-D7EC8584-543C-4DA0-B886-FECA2C741888

P2860

Q37809119-10F6D847-392B-4AD7-BEC0-11CE1D868A59

Q37809119-4F2A1FB7-8166-4A99-B3C0-5888267403F8

Q37809119-65881CDB-57CD-417E-BCD4-E0568B40CF99

Q37809119-7CADF38A-F7A1-46A0-B8F7-ED94DA05538A

Q37809119-FCFA1EC4-CC9D-4DB7-921E-C86DCEFC7130

P304

Q37809119-A181511C-5963-43DB-87E2-D2699DB080C9

P31

Q37809119-48917419-F3DA-4E69-AEE7-19861E061106

P356

Q37809119-EB97FD37-0AAD-439E-9719-425FE46D1DEF

P433

Q37809119-2F620924-3255-4B04-99D7-3CE07AF77C9E

P478

Q37809119-1CFAE022-74AA-41BC-9F66-9EA9FE2F6124

P577

Q37809119-F6305424-C211-47FF-A466-E0957CCF7161

P5875

Q37809119-0EEB67CA-AE35-4B6F-875A-4C044E8E6603

P698

Q37809119-8C715568-CF4B-45F0-810E-B85E01598BE0

P356

J.1478-3231.2010.02369.X

P1433

Liver International

P1476

Angiogenesis in chronic liver disease and its complications.

@en

P2093

Anja Geerts

http://www.w3.org/2001/XMLSchema#string

Christophe Van Steenkiste

http://www.w3.org/2001/XMLSchema#string

Femke Heindryckx

http://www.w3.org/2001/XMLSchema#string

Hans Van Vlierberghe

http://www.w3.org/2001/XMLSchema#string

Isabelle Colle

http://www.w3.org/2001/XMLSchema#string

Stephanie Coulon

http://www.w3.org/2001/XMLSchema#string

P2860

Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia

Effect of c-myc, Ki-67, MMP-2 and VEGF expression on prognosis of hepatocellular carcinoma patients undergoing tumor resection.

Expression of the platelet-derived growth factor beta receptor during organogenesis and tissue differentiation in the mouse embryo.

Relationship of the microvascular type to the tumor size, arterialization and dedifferentiation of human hepatocellular carcinoma.

Sinusoidal capillarization and arterial blood supply continuously proceed with the advance of the stages of hepatocarcinogenesis in the rat.

P304

146-162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1478-3231.2010.02369.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47789087

http://www.w3.org/2001/XMLSchema#string

P698

21073649

http://www.w3.org/2001/XMLSchema#string